三葉草生物(2197.HK)一度暴漲超90% 旗下新冠候選疫苗註冊申請預計四季度完成

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

三葉草生物(2197.HK)一度暴漲超90% 旗下新冠候選疫苗註冊申請預計四季度完成

格隆匯 11-08 15:15

格隆匯11月8日丨三葉草生物(2197.HK)盤中拉昇一度暴漲超90%報4.63港元，盤中一度觸發市調機制。據媒體消息，三葉草生物最新透露稱，旗下新冠候選疫苗SCB-2019向中國、歐洲和WHO遞交註冊申請的工作預計在2022年第四季度完成。

三葉草生物-B(02197.HK)

Relevant Stocks

三葉草生物-B(02197.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

三葉草生物(2197.HK)一度暴漲超90% 旗下新冠候選疫苗註冊申請預計四季度完成

Services

About Us

Agreement Statement